Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
Arthritis Research & Therapy 2005, 7:121-123 doi:10.1186/ar1742
- Last 30 days: 21 accesses
- Last 365 days: 358 accesses
- All time: 2797 accesses
These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information